The Continuous Evolution of LNPs
Research Background Lipid nanoparticles (LNPs) are an ideal carrier for delivering various drugs with poor in vivo stability, and they are widely used in drug development strategies for proteins, nucleic acids, and more. The launch of the world’s first siRNA drug, Patisiran, marked the transition of LNPs from laboratory research to clinical application, further highlighting … Read more